ALKS
Alkermes Plc
NASDAQ · Healthcare · Biotechnology · IE
$45.74
+0.11%Leverage
- Debt / equity
- 0.84x
- Net debt / equity
- 0.50x
- Debt / assets
- 0.35x
- Debt / EBITDA
- 8.79x
- Net debt / EBITDA
- 5.26x
Liquidity & coverage
- Current ratio
- 2.42x
- Quick ratio
- 2.02x
- Cash ratio
- 1.16x
- Interest coverage
- 0.74x
- EBITDA / interest
- 2.06x
- Working capital
- $928.8M
Cash & dividend
- FCF / debt
- 0.14x
- Cash flow / debt
- 0.15x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026